Depu Tripathy on Lower Risk for Recurrence of Early Stage Breast Cancer

Video

Dr. Debu Tripathy discusses the common treatments to help prevent recurrence of early stage breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, talks about current treatments to help prevent recurrence in patients with early-stage breast cancer.

Early-stage breast cancer is often very curable with surgery, but there are still instances of recurrence. To lower the risk, chemotherapy and hormonal drugs can be used. For patients with HER2+ breast cancer, there are the antibodies, trastuzimab (Herceptin) and pertuzumab (Perjeta).

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a man wearing scrubs in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
Related Content
Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background

A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

Bridget Hoyt
May 1st 2025
Article

Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Anatomical image of a breast with a tumor

Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer

John Novak, PA-C
Published: April 17th 2025 | Updated: May 5th 2025
Article

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the prioritization of quality of life.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

Close-up photo of a patient's hand being held by a the hands of a health care professional

Social Health Determinants Impact Psychoneurological Symptoms in BC Survivors

Kyle Doherty
April 11th 2025
Article

Social determinants of health like transportation and financial increased the occurrence of psychoneurological symptoms in breast cancer survivors.

Side profile anatomical rendering of a person, with breast tissue and a breast tumor in orange

Vepdegestrant Meets PFS End Point for Metastatic Breast Cancer Subtype

Ashley Chan
March 25th 2025
Article